Discover open access scientific publications

Search, annotate, share and cite publications

Publications by E. Duteil

Pcn126 - Direct Cost Study of Allogeneic Hematopoietic Stem Cell Transplantation (Ahsct) for Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia Patients From the French Hospital Perspective

Value in Health

English

Pcn124 - Direct Cost of Allogeneic Hematopoietic Stem Cell Transplantation (Ahsct) for Relapsed/Refractory (Rr) Diffuse Large B-Cell Lymphoma Patients From the French Hospital Perspective

English

Related publications

CAR-T Cells and Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia

English

Favorable Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed or Refractory Acute Promyelocytic Leukemia in Childhood

Bone Marrow Transplantation

Transplantation

Hematology

2004

English

Prophylaxis and Treatment of Acute Lymphoblastic Leukemia Relapse After Allogeneic Hematopoietic Stem Cell Transplantation

OncoTargets and Therapy

Oncology

Pharmacology

2015

English

Outcomes in Patients With Relapsed or Refractory Acute Promyelocytic Leukemia Treated With or Without Autologous or Allogeneic Hematopoietic Stem Cell Transplantation

Clinical Lymphoma, Myeloma and Leukemia

English

CTL019 (Tisagenlecleucel): CAR-T Therapy for Relapsed and Refractory B-Cell Acute Lymphoblastic Leukemia

Drug Design, Development and Therapy

Drug Discovery

Pharmacology

Pharmaceutical Science

2018

English

Extramedullary Relapse of Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation

Biology of Blood and Marrow Transplantation

Transplantation

Hematology

2016

English

Outcomes of Hematopoietic Stem Cell Transplantation (HSCT) Among Adults With Relapsed/Refractory (R/R) Acute Lymphoblastic Leukemia (ALL) Achieving Remission With Blinatumomab

Biology of Blood and Marrow Transplantation

Transplantation

Hematology

2016

English

Therapy With Imatinib Mesylate (Glivec) Preceding Allogeneic Stem Cell Transplantation (SCT) in Relapsed or Refractory Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph+ALL)

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by E. Duteil

Pcn126 - Direct Cost Study of Allogeneic Hematopoietic Stem Cell Transplantation (Ahsct) for Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia Patients From the French Hospital Perspective

Pcn124 - Direct Cost of Allogeneic Hematopoietic Stem Cell Transplantation (Ahsct) for Relapsed/Refractory (Rr) Diffuse Large B-Cell Lymphoma Patients From the French Hospital Perspective

Related publications

CAR-T Cells and Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia

Favorable Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed or Refractory Acute Promyelocytic Leukemia in Childhood

Prophylaxis and Treatment of Acute Lymphoblastic Leukemia Relapse After Allogeneic Hematopoietic Stem Cell Transplantation

Outcomes in Patients With Relapsed or Refractory Acute Promyelocytic Leukemia Treated With or Without Autologous or Allogeneic Hematopoietic Stem Cell Transplantation

CTL019 (Tisagenlecleucel): CAR-T Therapy for Relapsed and Refractory B-Cell Acute Lymphoblastic Leukemia

Extramedullary Relapse of Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation

Outcomes of Hematopoietic Stem Cell Transplantation (HSCT) Among Adults With Relapsed/Refractory (R/R) Acute Lymphoblastic Leukemia (ALL) Achieving Remission With Blinatumomab

Therapy With Imatinib Mesylate (Glivec) Preceding Allogeneic Stem Cell Transplantation (SCT) in Relapsed or Refractory Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph+ALL)